Although the attached document regarding the sales and market status of hydrophilic implants does not include specific sales data or market share statistics, the general status of the dental medical device market is as follows:

Market Domination by Major Global and Domestic Companies with Hydrophilic Products: Straumann, the global leader in the implant market, has firmly maintained its number one global market share by developing its proprietary hydrophilic surface treatment technology, "SLActive." Domestic companies have also significantly expanded their market presence by launching products that highlight superhydrophilic surfaces (e.g., Osstem Implant's "BA" lineup, DIO's "DIO UV Implant," and Cowellmedi's "INNO SLA").

Rising Sales Driven by Demand for Shortened Treatment Times: As both clinicians (dentists) and patients prefer premium implants that shorten treatment times and achieve stable osseointegration—even in conditions with insufficient jawbone volume—sales of hydrophilic implants are showing a continuous upward trend. In fact, domestic company DIO demonstrated rapid growth, with its UV hydrophilic implant product line surpassing a cumulative sales volume of 90,000 units.

Technological Trend Established in the Market: While the market in the past focused solely on creating rough surfaces (such as SLA), it has recently evolved beyond that. Maximizing surface energy and removing contaminants through "hydrophilicity enhancement" technologies have now become the industry standard and a core competitive advantage, leading to a steadily increasing share of these products in overall sales.